| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 02/10/2004 | US6689909 Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 02/10/2004 | US6689896 Thyromimetic organic compounds |
| 02/10/2004 | US6689882 Reacting a morpholine with a substituted benzene, wherein morpholine is used as a reactant and as the only one solvent |
| 02/10/2004 | US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase |
| 02/10/2004 | US6689174 N-benzyl-p-phenylenediamine-derivatives containing coloring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives |
| 02/05/2004 | WO2004011449A2 Method for the production of phenylalanine derivatives |
| 02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 02/05/2004 | WO2004011410A1 Chemical compounds |
| 02/05/2004 | WO2004011004A1 Formulation of liposomal derivatives of phenylalanine |
| 02/05/2004 | WO2004010942A2 Substituted heterocyclic compounds as modulators of the ccr5 receptor |
| 02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
| 02/05/2004 | WO2003051348A3 Composition, synthesis and therapeutic applications of polyamines |
| 02/05/2004 | US20040024215 Such as 4'-trifluoromethyl-biphenyl-2-carboxylic acid(4-(4-(alpha-methyl-benzyl)-piperazin-1-yl)-phenyl)-amide; apoprotein B-100 (apoB-100) and microsomal triglyceride transfer protein (MTP) |
| 02/05/2004 | US20040024209 Drugs such as 4-(3-Bromo-4-fluorobenzyl)morpholine used as viricides against herpes viruses |
| 02/05/2004 | US20040024205 Monomethylation of nitrogeneous heterocycles |
| 02/05/2004 | US20040024067 Deacetylase inhibitors |
| 02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
| 02/05/2004 | US20040024057 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications |
| 02/05/2004 | US20040023945 Cyclic amp-specific phosphodiesterase inhibitors |
| 02/05/2004 | US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi. |
| 02/05/2004 | US20040022856 Carriers for drug delivery |
| 02/05/2004 | US20040022831 For therapy of mycosis of the nail |
| 02/05/2004 | DE10238048A1 Verfahren zur Herstellung von Phenylalanin-Derivaten Process for the preparation of phenylalanine derivatives |
| 02/05/2004 | DE10234058A1 Neue substituierte Benzoesäureamide, deren Herstellung und deren Verwendung als Arzneimittel New substituted benzamides, their preparation and their use as medicaments |
| 02/05/2004 | DE10234057A1 Neue Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel New carboxamides, their preparation and their use as medicaments |
| 02/05/2004 | DE10233632A1 Formulierungen von Phenylalanin-Derivaten Formulations of phenylalanine derivatives |
| 02/05/2004 | CA2494668A1 Chemical compounds |
| 02/04/2004 | EP1386916A1 Process for the monomethylation of nitrogen containing heterocycles |
| 02/04/2004 | EP1385625A2 A nickel-rhenium catalyst for use in reductive amination processes |
| 02/04/2004 | EP1385508A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/04/2004 | EP1115697B1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 02/04/2004 | CN1473158A Radiopharmaceuticals for diagnosing alzheimer's disease |
| 02/04/2004 | CN1137118C Water soluble azoles as broad-spectrun antifungals |
| 02/03/2004 | US6686502 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 02/03/2004 | US6686484 Anticoagulants; serine protease inhibitor |
| 02/03/2004 | US6686467 Inhibitors of the production of cytokines such as tumour necrosis factor (hereinafter tnf), for example tnf alpha , and various members of the interleukin (hereinafter il) family, for example il-1, il-6 and il-8 |
| 02/03/2004 | US6686424 Preparation of functionalized alkoxyamine initiator and its use |
| 02/03/2004 | US6686360 N-benzylpiperazine compounds |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 02/03/2004 | CA2355987C Bicyclic amide derivatives and their use as muscle relaxants |
| 02/01/2004 | CA2434481A1 Process for the methylation of nitrogenated heterocyclics |
| 01/29/2004 | WO2004009603A1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods |
| 01/29/2004 | WO2004009578A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 01/29/2004 | WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | WO2004009531A1 Acetylenic compounds useful in treating inflammatory disorders |
| 01/29/2004 | WO2004009086A1 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 01/29/2004 | WO2004009034A2 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019117 Anti tubercular drug: compostions and methods |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040019087 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | US20040019086 Aminediols for the treatment of Alzheimer's disease |
| 01/29/2004 | US20040019043 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | US20040019039 Substituted piperazines and diazepanes |
| 01/29/2004 | US20040019023 Administering 9,10-secopregna-5,7,10(19),16- tetraene derivative to a patient for treating skin diseases such as psoriasis |
| 01/29/2004 | DE10232525A1 Neue Anthracen-Derivate und deren Verwendung als Arzneimittel Novel anthracene derivatives and their use as medicaments |
| 01/29/2004 | CA2493127A1 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | CA2492907A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/28/2004 | EP1384719A1 Inhibitors of the glucosyl ceramide synthase enzyme useful for the treatment of cancers, sphingolipidosis and microbial infections |
| 01/28/2004 | EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors |
| 01/28/2004 | EP1383753A1 Piperazine-benzamide derivatives useful as apob-100 and/or mtp inhibitor |
| 01/28/2004 | EP1383752A2 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 01/28/2004 | EP1383750A2 Urea derivatives as integrin alpha 4 antagonists |
| 01/28/2004 | EP1383748A2 Novel compounds and compositions as cathepsin inhibitors |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | EP1383730A2 Anticholinergic compounds and methods of use |
| 01/28/2004 | EP1000016B1 Isocyanoalkyl carbonic acid derivatives, their conversion into secondary amidoalkyl carbonic acid derivatives by isocyanide-multicomponent reactions, as well as these secondary amidoalkyl carbonic acid derivatives. |
| 01/28/2004 | CN1471516A Process for the preparation of 1,5-disubstituted-3-amino-1,2,4-triazoles and substituted aminoguamidines as intermediate compounds |
| 01/28/2004 | CN1471509A 9-substituted minocycline compounds |
| 01/28/2004 | CN1471506A Method for preparing carbonyl alpha-substituted nitrogen compounds |
| 01/28/2004 | CN1136192C Aryl and hetaryl-sulfonamide derivatives, their preparation and use as endo thelin antagonists |
| 01/28/2004 | CN1136187C 1-amino-alkylcyclohexane NMDA receptor antagonists |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683184 Piperazine derivatives and process for the preparation thereof |
| 01/27/2004 | US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/27/2004 | US6683074 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/27/2004 | CA2214720C Arylsulfonylamino hydroxamic acid derivatives |
| 01/22/2004 | WO2004007471A1 N-phenyl-(2r,5s)dimethylpiperadine derivative |
| 01/22/2004 | WO2004007470A1 Novel anthracene derivatives and the use thereof as a medicament |
| 01/22/2004 | WO2004007439A1 Biaryl derivatives |
| 01/22/2004 | WO2004007437A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | WO2004006878A1 Merocyanine derivatives for cosmetic use |
| 01/22/2004 | WO2003072030A3 Methods for preventing or treating cardiac arrhythmia |
| 01/22/2004 | WO2003049690A3 Hiv integrase inhibitors |
| 01/22/2004 | US20040014971 N-(4-(4-(2-oxo-1-phenyl-2-((2,2,2-trifluoroethyl)amino)ethyl)-1 -piperazinyl)-phenyl)-4'-(trifluoromethyl)-(1,1'-biphenyl)-2-carboxamide for treatment of obesity, diabetes, and cardiovascular disorders; decreases apoplioprotein secretion |
| 01/22/2004 | US20040014966 Such as 2-(phenylsulfonyl)-5-(1-piperazinyl)phenylamine which is a 5-HT receptor ligand; for performing positron emission tomography, nuclear magnetic resonance |
| 01/22/2004 | US20040014796 Antiinflammatory agents; rheumatic diseases; antitumor agents |
| 01/22/2004 | US20040014784 Substituted propargylamines |
| 01/22/2004 | US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014745 Amide compounds |
| 01/22/2004 | CA2493373A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/21/2004 | EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria |
| 01/21/2004 | EP1381594A1 Urea compounds useful as anti-inflammatory agents |
| 01/21/2004 | EP1381591A2 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP1381357A2 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |